- Home
- LEU vs CRMD Comparison
LEU vs CRMD Comparison
Compare LEU & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEU
- CRMD
- Stock Information
- Founded
- LEU 1998
- CRMD 2006
- Country
- LEU United States
- CRMD United States
- Employees
- LEU N/A
- CRMD N/A
- Industry
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- LEU Industrials
- CRMD Health Care
- Exchange
- LEU Nasdaq
- CRMD Nasdaq
- Market Cap
- LEU 3.1B
- CRMD 973.3M
- IPO Year
- LEU 1998
- CRMD 2010
- Fundamental
- Price
- LEU $177.16
- CRMD $11.35
- Analyst Decision
- LEU Buy
- CRMD Strong Buy
- Analyst Count
- LEU 9
- CRMD 7
- Target Price
- LEU $165.63
- CRMD $17.33
- AVG Volume (30 Days)
- LEU 1.4M
- CRMD 2.4M
- Earning Date
- LEU 08-05-2025
- CRMD 08-13-2025
- Dividend Yield
- LEU N/A
- CRMD N/A
- EPS Growth
- LEU 40.85
- CRMD N/A
- EPS
- LEU 6.39
- CRMD 0.28
- Revenue
- LEU $471,400,000.00
- CRMD $82,553,827.00
- Revenue This Year
- LEU $3.22
- CRMD $238.38
- Revenue Next Year
- LEU $9.91
- CRMD $53.52
- P/E Ratio
- LEU $27.19
- CRMD $40.64
- Revenue Growth
- LEU 58.72
- CRMD N/A
- 52 Week Low
- LEU $33.51
- CRMD $3.61
- 52 Week High
- LEU $211.31
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- LEU 59.65
- CRMD 38.32
- Support Level
- LEU $167.26
- CRMD $11.21
- Resistance Level
- LEU $188.50
- CRMD $11.74
- Average True Range (ATR)
- LEU 16.45
- CRMD 0.64
- MACD
- LEU -3.16
- CRMD -0.45
- Stochastic Oscillator
- LEU 43.37
- CRMD 2.25
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.